Target intelligence / Profile preview

Inverted terminal repeats of the TcBuster DNA transposon (TcBuster ITRs)

Target
TcBuster ITRs
Molecular classification
DNA element, Mobile genetic element, hAT superfamily element
01

Overview

TcBuster is a DNA transposon belonging to the hAT (hobo-Ac-Tam3) superfamily, originally identified in the red flour beetle Tribolium castaneum (Woodard & Wilson, 2015). The inverted terminal repeats (ITRs) are essential DNA sequences located at the ends of the transposon that serve as the specific recognition sites for the TcBuster transposase enzyme (Hacker et al., 2017). In the field of gene therapy, the TcBuster system is utilized as a non-viral vector for the stable integration of therapeutic genes into the host genome. The transposase recognizes the ITRs and performs a cut-and-paste mechanism, excising the DNA segment between the repeats and inserting it into the target cell's DNA (Ammar et al., 2012). This system is increasingly used in the manufacturing of chimeric antigen receptor (CAR) T-cells due to its ability to carry large genetic payloads and its high integration efficiency in human primary cells (Luminary Therapeutics, 2023). Compared to viral vectors, the TcBuster system offers potential advantages in terms of reduced manufacturing costs and improved safety profiles regarding immunogenicity. However, like all integrating vectors, it carries risks of insertional mutagenesis and requires careful monitoring of integration sites (Gogol-Döring et al., 2016). The ITRs are the critical structural components that define the boundaries of the genetic material to be transferred.

Other names
TcB ITRsTcBuster terminal repeatsTcBuster inverted repeatsTcBuster DNA recognition sequences
02

Mechanism of action

Transposase-mediated cut-and-paste DNA transposition involving excision from a donor plasmid and integration into the host genome.

03

Biological functions

DNA transpositionGenetic recombinationStable gene integrationDNA binding
04

Disease associations

CancerGenetic disorderHematologic malignancy
05

Safety considerations

Insertional mutagenesisGenotoxicityOff-target integrationOncogenic activationPersistent transposase expression
06

Interacting drugs

TcBuster transposase

3 more in the full profile.

07

Biomarkers

Vector copy number (VCN)Integration site profileTransgene expression levelsResidual transposase mRNA/protein

Beyond the preview

Go deeper on Inverted terminal repeats of the TcBuster DNA transposon (TcBuster ITRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inverted terminal repeats of the TcBuster DNA transposon (TcBuster ITRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call